This was a retrospective analysis of images acquired in subjects with ocular hypertension taking part in a clinical trial
32 and normal subjects, without risk factors for glaucoma,
33 under observation in the Glaucoma Research Unit at Moorfields Eye Hospital. The two cohorts of subjects comprised 31 converters and 19 normal subjects (both defined later). The demographics of the subjects identified for this study are summarized in
Table 1 . All subjects were imaged with the HRT during a 7-year follow-up (1994–2001) and had undergone HRT imaging and perimetry at least six times. Different operators with various levels of experience had acquired the images because of turnover in research clinic technical staff over the period. The study adhered to the tenets of the Declaration of Helsinki and had appropriate institutional review board approval and the subjects’ informed consent.
Normal subjects were volunteers: spouses or friends of hospital patients, hospital staff, or members of external nonmedical social organizations. They had IOP persistently less than 22 mm Hg, normal and reliable serial visual field (VF) results (Humphrey 24-2; Carl Zeiss Meditec, Inc, Dublin, CA), with an Advanced Glaucoma Intervention Study (AGIS) score of 0, no concurrent ocular disease, no family history of glaucoma, and refractive error less than 6 D. All were older than 40 years. The appearance of the ONH was not taken into account for entry into the study.
Converters initially had a diagnosis of ocular hypertension (IOP > 22 mm Hg); open angles on gonioscopy, refractive error less than 6 D, and no concurrent ocular disease and were older than 40 years. All had initially normal VF results (Humphrey 24- 2; AGIS score = 0) and began to show VF defects during the course of monitoring (AGIS VF score changed from 0 to >1 in three consecutive VF examinations, with the defect at the same test-point location).